Skip to main content

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Blog
    • Collections
    • Podcast
  • TOPICS
    • Cognition and Behavior
    • Development
    • Disorders of the Nervous System
    • History, Teaching and Public Awareness
    • Integrative Systems
    • Neuronal Excitability
    • Novel Tools and Methods
    • Sensory and Motor Systems
  • ALERTS
  • FOR AUTHORS
  • ABOUT
    • Overview
    • Editorial Board
    • For the Media
    • Privacy Policy
    • Contact Us
    • Feedback
  • SUBMIT

User menu

Search

  • Advanced search
eNeuro

eNeuro

Advanced Search

 

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Blog
    • Collections
    • Podcast
  • TOPICS
    • Cognition and Behavior
    • Development
    • Disorders of the Nervous System
    • History, Teaching and Public Awareness
    • Integrative Systems
    • Neuronal Excitability
    • Novel Tools and Methods
    • Sensory and Motor Systems
  • ALERTS
  • FOR AUTHORS
  • ABOUT
    • Overview
    • Editorial Board
    • For the Media
    • Privacy Policy
    • Contact Us
    • Feedback
  • SUBMIT
PreviousNext
Research ArticleResearch Article: New Research, Neuronal Excitability

Precision Mapping of Amyloid-β Binding Reveals Perisynaptic Localization and Spatially Restricted Plasticity Deficits

Hannah S. Actor-Engel, Samantha L. Schwartz, Kevin C. Crosby, Brooke L. Sinnen, Olga Prikhodko, Harrison J. Ramsay, Jennifer N. Bourne, Christina S. Winborn, Alexandra Lucas, Katharine R. Smith, Mark L. Dell’Acqua and Matthew J. Kennedy
eNeuro 17 November 2021, 8 (6) ENEURO.0416-21.2021; DOI: https://doi.org/10.1523/ENEURO.0416-21.2021
Hannah S. Actor-Engel
1Department of Pharmacology, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, CO 80045
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Samantha L. Schwartz
1Department of Pharmacology, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, CO 80045
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kevin C. Crosby
1Department of Pharmacology, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, CO 80045
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brooke L. Sinnen
1Department of Pharmacology, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, CO 80045
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Olga Prikhodko
1Department of Pharmacology, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, CO 80045
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Harrison J. Ramsay
1Department of Pharmacology, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, CO 80045
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Harrison J. Ramsay
Jennifer N. Bourne
2Electron Microscopy Core, University of Colorado Anschutz Medical Campus, Aurora, CO 80045
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christina S. Winborn
1Department of Pharmacology, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, CO 80045
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexandra Lucas
1Department of Pharmacology, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, CO 80045
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katharine R. Smith
1Department of Pharmacology, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, CO 80045
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark L. Dell’Acqua
1Department of Pharmacology, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, CO 80045
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthew J. Kennedy
1Department of Pharmacology, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, CO 80045
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Matthew J. Kennedy
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Figures & Data

Figures

  • Extended Data
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Kinetics of Aβ association and dissociation at synaptic sites. A, Representative dendritic segment from a neuron transfected with mCherry (red) and PSD95FingR-GFP (green) treated with labeled Aβo (teal) for 10 min. Closed arrowheads denote dendritic spines labeled with Aβo and the open arrowhead denotes a spine lacking Aβo. Fluorescent Aβ was confirmed to form oligomeric species and block LTP in Extended Data Figure 1-1. Scale bar: 1 μm. B, Representative image series of Aβo accumulation on a spine excitatory synapse. Aβo was added at 0 s. Scale bar: 1 μm. C, left, Quantification of Aβo association kinetics at PSD95-positive dendritic spines or neighboring PSD95-negative dendritic shafts (n = 10 neurons, 4 independent cultures). Right, Plateau intensity values for Aβo binding at PSD95+ versus PSD95– (shaft) locations on the same cell (n = 10 neurons; p = 0.0139, paired Student’s t test). D, Representative image of Aβo localization to spine (arrow) and shaft (arrowhead) PSD95. Scale bar: 1 μm. E, left, Aβo binding kinetics at PSD95 puncta on spines or shafts (n = 20 PSD95 puncta from 5 neurons, 3 independent cultures). Right, Plateau intensity values of Aβo at PSD95 puncta on the spine and shaft of the same neuron (n = 5 neurons, p = 0.2857, paired Student’s t test). ns = not significant. F, Representative image sequence of Aβo (teal) bound to a dendritic spine following washout into Aβo-free imaging media at t = 0 min. The cell outline is shown as a dashed line, drawn based on a cell fill (data not shown). Scale bar: 1 μm. G, Quantification of Aβo intensity following washout. Data are plotted as F/F0, with F0 representing normalized Aβo signal immediately before washout (n = 5 neurons). H, Representative image of a dendrite from a hippocampal neuron expressing mCh (dotted line), treated with labeled Aβo (cyan, left panel) for 10 min and then an extracellular antibody against Aβo to assess surface localization (green). Scale bar: 1 μm. I, Fraction of Aβo puncta (averaged per cell) labeled with an extracellular antibody (i.e., localized to the cell surface) 10 and 45 min following Aβo application (n = 5 neurons per group, two independent cultures). ns = not significant, Student’s t test. J, Representative time series for FRAP experiments. Shown is a single Aβo-bound spine. The Aβo signal was photobleached and signal recovery was monitored over time. Arrowheads indicate the location of photobleaching and signal recovery. Scale bar: 1 μm. K, Kinetics and extent of Aβo recovery following photobleaching in the continued presence (no wash, orange) or absence (wash, red) of Aβo in the extracellular solution (wash: n = 23 spines, from 6 neurons and 2 independent cultures; no wash: n = 12 spines from 4 neurons and 2 independent cultures). Quantification of the mobile Aβo fraction is shown to the right under each condition (***p = 0.0007, Student’s t test).

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    Super-resolution localization of Aβo relative to excitatory and inhibitory synapses. A, Representative SIM images of Aβo (teal) with excitatory synaptic proteins PSD95 (yellow), GluA1 (red), and the inhibitory synaptic protein Gephyrin (green). Bottom panels show control, GluA1 (red) with PSD95 (yellow). Scale bars: 1 μm. B, Expanded regions showing individual synapses from panel A. Scale bars: 500 nm. The graphs to the right of each example plot pixel intensities for each channel along a line drawn diagonally through representative synapses. 3D volume renderings of masked and segmented synapses are shown to the right. C, Approach for quantifying the spatial relationship between synaptic proteins and Aβo. i, Representative SIM image showing PSD95 (green) and Aβo (cyan). The outline of the cell (dashed line) was drawn using the signal from an mCh cell fill (data not shown). ii, The Aβo signal (cyan) is masked and binarized (blue). Right, PSD95 (green) is masked and binarized (red). iii, Magnified red box from ii. The number of Aβo puncta are counted at increasing concentric voxel distances around masked synaptic marker. D, The number of Aβo puncta (quantified as described in panel B) at different distances from either PSD95 (orange; n = 48 neurons) or gephyrin (green; n = 18 neurons), normalized to randomly localized simulated data (black; average of seven independent simulations). A value of 1 indicates no spatial relationship, >1 a positively correlated spatial relationship, and <1 a negatively correlated spatial relationship. E, Aβo is enriched near the excitatory PSD. Plotted is the average number density of segmented Aβo puncta 0–64 nm from PSD95, GluA1, or gephyrin (PSD95 n = 48 neurons, GluA1 n = 16 neurons, gephyrin n = 18 neurons). The average number density of the synaptic protein GluA1 relative to PSD95 is plotted for comparison (n = 7 neurons); ****p < 0.0001, one-way ANOVA. ns = not significant.

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3.

    Single molecule localization microscopy reveals Aβo forms nanoscale clusters immediately adjacent to the synaptic membrane. A, Representative dSTORM images of synapses from hippocampal neurons labeled with PSD95 (magenta) that were treated with 500 nm Aβo (cyan) for 10 min. Three examples of raw localization data are shown. The bottom panels display localizations using a density-based lookup table with warmer colors representing higher density regions. The segmented PSD is shaded in gray. Scale bar: 200 nm. B, Representative dSTORM image of GluA1 (cyan) and PSD95 (magenta). Raw localizations are shown in the top panels and the bottom panels are rendered as in A. Scale bar: 200 nm. C, Quantification of the fraction of individual spine Aβo localizations that fall within the segmented PSD95 at single synapses (left; n = 24 synapses, 5 cells, 2 independent cultures). The same analysis is shown for GluA1 for comparison (right; n = 64 synapses, 11 cells, 3 independent cultures); ***p < 0.0001, Student’s t test. D, Frequency histograms are shown plotting the fraction overlap of segmented Aβo clusters (left) or GluA1 clusters (right) with the PSD. A value of 0 indicates no overlap with the PSD while a value of 1 indicates the cluster fell entirely within the PSD. Intermediate values indicate clusters that fell on the edge of the segmented PSD.

  • Figure 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4.

    Aβo binds at both presynaptic and postsynaptic sites. A, Representative postembedding immunogold electron micrograph of a synapse exposed to 500 nm Aβo and labeled with an Aβ antibody and gold-conjugated secondary. The green box (magnified in inset) highlights immunogold signal. Gold particles within 20 nm of the cell membrane were considered plasma membrane-associated based on the size of the primary and secondary labeling antibodies. Scale bar: 200 nm. B, Quantification of total membrane-associated Aβo (measured as total number of gold particles per linear micron of plasma membrane) from samples treated with PBS alone or PBS with 500 nm Aβo. (PBS: n = 60 spines; Aβ: n = 66 spines; p < 0.0001, Mann–Whitney test). C, Quantification of Aβo label on the presynaptic or postsynaptic membrane (p = 0.0005, Mann–Whitney test). D, Percentage of the total dendritic spine gold particles that localized directly at the PSD or perisynaptic regions within 200 nm of the PSD (n = 27 gold particles). E, Representative image of a dendritic segment processed for ExM, labeled for presynaptic bassoon (green), postsynaptic GluA1 (red), and Aβo (cyan). The lower panels show two representative synapses (labeled 1 and 2) from the larger image and their respective 3D volume renderings. F, top, Schematic of the analysis used to quantify presynaptic and postsynaptic Aβo signal. The synaptic axis is defined by a line drawn between the centers of mass of masked bassoon (presynaptic marker) and GluA1 (postsynaptic marker) signals. A vector is generated from the middle of the pre/post axis to the center of mass of the segmented Aβo, with the component vectors representing the radial distance from the synapse center (r) and the distance along the pre/post axis (z). Bottom, Quantification of Aβo signal along the pre/post and radial axes. Negative and positive values indicate postsynaptic and presynaptic localization respectively. The number of Aβo puncta at different distances along the pre/post axis are summed and plotted in the histogram to the right (n = 89 synapses from 26 neurons from 3 independent cultures).

  • Figure 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 5.

    Aβo-mediated plasticity impairment is locally restricted near sites of surface binding. A, left, Representative image of a dendritic segment from a neuron transfected with tdTomato (red) and treated with Aβo-488 (teal). Asterisks designate the location of MNI-glutamate uncaging. The closed arrowhead shows a spine with bound Aβo (Aβ+), and the open arrowhead shows a neighboring spine lacking Aβo (Aβ–). Right, Time course of Aβo– spine (top) and Aβo+ spine (bottom) from the same dendritic segment before the uncaging stimulus and up to 24 min following the stimulus. Scale bars: 5 μm (left panel) and 1 μm (right panels). B, Quantification of spine size (based on the cell fill intensity) before and after MNI-glutamate uncaging for control spines not treated with Aβo (blue, n = 14 spines, N = 5 neurons, 3 independent cultures), adjacent spines that were not stimulated (green, n = 12 spines, N = 5 neurons, 3 independent cultures), Aβ+ spines from cultures treated with 500 nm Aβo for at least 25 min (maroon, n = 16 spines, N = 8 neurons, 3 independent cultures), and neighboring Aβo-lacking spines (black, n = 14 spines, 8 neurons, 3 independent cultures). C, Average increase in spine cell fill signal during the final 3 min of imaging compared with baseline for control (n = 14 spines, N = 5 neurons, 3 independent cultures), Aβo+ (n = 16 spines, N = 8 neurons, 3 independent cultures), and Aβo– (n = 14 spines, 8 neurons, 3 independent cultures; *p ≤ 0.05, Student’s t test). ns = not significant. D, Average F/F0 over the final 3 min of imaging compared with baseline at Aβo-bound spines and neighboring Aβo-free spines on the same neurons (eight neurons, three independent cultures, *p = 0.0116, paired t test).

Extended Data

  • Figures
  • Extended Data Figure 1-1

    Fluorescent Aβ peptide forms oligomers that disrupt LTP. A, HiLyte647-conjugated Aβ peptide forms oligomeric species. Shown is an immunoblot (probed with anti-Aβ 6E10) of Aβo prepared with HiLyte647-labeled peptide. Note the presence of putative dimers (1), trimers (2), and higher molecular weight species (3) in the preparation. B, Aβo prepared with HiLyte647-labeled peptide disrupts LTP measured by EPSP slope (left) or peak EPSP amplitude (right). LTP was induced by delivering 2 × 1-s trains of 100-Hz stimulation spaced 5 min apart (arrows). Slices were exposed to Aβo for 20 min prior to LTP induction. n = 8 slices from 8 animals, control; 6 slices from 6 animals Aβo treated. C, Representative EPSPs from control (left) or Aβo-treated (right) slices before (black) and 45 min following (gray) LTP induction. D, Average EPSP slope (left) and amplitude (right) for control (PBS treated) or Aβo-treated slices 45 min following LTP induction. The dashed line represents baseline; *p < 0.05, Student’s t test. Download Figure 1-1, TIF file.

Back to top

In this issue

eneuro: 8 (6)
eNeuro
Vol. 8, Issue 6
November/December 2021
  • Table of Contents
  • Index by author
  • Ed Board (PDF)
Email

Thank you for sharing this eNeuro article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Precision Mapping of Amyloid-β Binding Reveals Perisynaptic Localization and Spatially Restricted Plasticity Deficits
(Your Name) has forwarded a page to you from eNeuro
(Your Name) thought you would be interested in this article in eNeuro.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
View Full Page PDF
Citation Tools
Precision Mapping of Amyloid-β Binding Reveals Perisynaptic Localization and Spatially Restricted Plasticity Deficits
Hannah S. Actor-Engel, Samantha L. Schwartz, Kevin C. Crosby, Brooke L. Sinnen, Olga Prikhodko, Harrison J. Ramsay, Jennifer N. Bourne, Christina S. Winborn, Alexandra Lucas, Katharine R. Smith, Mark L. Dell’Acqua, Matthew J. Kennedy
eNeuro 17 November 2021, 8 (6) ENEURO.0416-21.2021; DOI: 10.1523/ENEURO.0416-21.2021

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Share
Precision Mapping of Amyloid-β Binding Reveals Perisynaptic Localization and Spatially Restricted Plasticity Deficits
Hannah S. Actor-Engel, Samantha L. Schwartz, Kevin C. Crosby, Brooke L. Sinnen, Olga Prikhodko, Harrison J. Ramsay, Jennifer N. Bourne, Christina S. Winborn, Alexandra Lucas, Katharine R. Smith, Mark L. Dell’Acqua, Matthew J. Kennedy
eNeuro 17 November 2021, 8 (6) ENEURO.0416-21.2021; DOI: 10.1523/ENEURO.0416-21.2021
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Significance Statement
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
    • Synthesis
    • Author Response
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Keywords

  • amyloid-β
  • LTP
  • plasticity
  • postsynaptic density
  • super-resolution
  • synapse

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.

Related Articles

Cited By...

More in this TOC Section

Research Article: New Research

  • Synaptotagmin-7 Enhances Facilitation of Cav2.1 Calcium Channels
  • Sex Differences in the Spatial Behavior Functions of Adult-Born Neurons in Rats
  • Multimodal, Multiscale Insights into Hippocampal Seizures Enabled by Transparent, Graphene-Based Microelectrode Arrays
Show more Research Article: New Research

Neuronal Excitability

  • Glutamate transporters EAAT2 and EAAT5 differentially shape synaptic transmission from rod bipolar cell terminals
  • Synaptotagmin-7 Enhances Facilitation of Cav2.1 Calcium Channels
  • VGLUT3 Ablation Differentially Modulates Glutamate Receptor Densities in Mouse Brain
Show more Neuronal Excitability

Subjects

  • Neuronal Excitability

  • Home
  • Alerts
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Latest Articles
  • Issue Archive
  • Blog
  • Browse by Topic

Information

  • For Authors
  • For the Media

About

  • About the Journal
  • Editorial Board
  • Privacy Policy
  • Contact
  • Feedback
(eNeuro logo)
(SfN logo)

Copyright © 2022 by the Society for Neuroscience.
eNeuro eISSN: 2373-2822

The ideas and opinions expressed in eNeuro do not necessarily reflect those of SfN or the eNeuro Editorial Board. Publication of an advertisement or other product mention in eNeuro should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in eNeuro.